APA (7th ed.) Citation

EA, B., C, G., B, T., SR, P., & K, A. (2021). Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management. Diseases (Basel, Switzerland), 9(1), . https://doi.org/10.3390/diseases9010020

Chicago Style (17th ed.) Citation

EA, Burns, Gentille C, Trachtenberg B, Pingali SR, and Anand K. "Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management." Diseases (Basel, Switzerland) 9, no. 1 (2021). https://doi.org/10.3390/diseases9010020.

MLA (9th ed.) Citation

EA, Burns, et al. "Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management." Diseases (Basel, Switzerland), vol. 9, no. 1, 2021, https://doi.org/10.3390/diseases9010020.